A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 361 participants.
Also called NCT01584232
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 361 participants
- Sponsor
- Registry
-
NCT01584232
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01584232. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2013-07 (actual). Results posted on 2014-10-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- LY2189265
- Intervention (Drug)
- Insulin glargine
- Intervention (Drug)
- Sulfonylureas (SU)
- Intervention (Drug)
- Biguanide (BG)
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01584232- Content hash
bc07b0fcd2fcd771c6a0be92a33fd8681717eadf6afec4b9f8b3fe7a3d1f2f65